Non-thrombocytopenic Bleeding Associated with Trastuzumab Emtansine in HER2-Positive Breast Cancer: A Real-World Case Series
Indian Journal of Gynecologic Oncology · 2026-06 · 24 (2)
DOI: 10.1007/s40944-026-01095-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Gynecologic Oncology, online erschienen am 19.03.2026. Verfasst von Krishna Ratanchandani und 3 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ratanchandani, K., Joshi, V., Patil, C. N., & Mankada, S. (2026). Non-thrombocytopenic Bleeding Associated with Trastuzumab Emtansine in HER2-Positive Breast Cancer: A Real-World Case Series. Indian Journal of Gynecologic Oncology, 24(2). https://doi.org/10.1007/s40944-026-01095-4
Vancouver
Ratanchandani K, Joshi V, Patil CN, Mankada S. Non-thrombocytopenic Bleeding Associated with Trastuzumab Emtansine in HER2-Positive Breast Cancer: A Real-World Case Series. Indian Journal of Gynecologic Oncology. 2026;24(2). doi:10.1007/s40944-026-01095-4
BibTeX
@article{Ratanchandani2026,
author = {Ratanchandani, Krishna and Joshi, Vaishnavi and Patil, C. N. and Mankada, Sakina},
title = {Non-thrombocytopenic Bleeding Associated with Trastuzumab Emtansine in HER2-Positive Breast Cancer: A Real-World Case Series},
journal = {Indian Journal of Gynecologic Oncology},
year = {2026},
volume = {24},
number = {2},
doi = {10.1007/s40944-026-01095-4}
}
EUVIMED